Clarity Pharmaceuticals (ASX:CU6) Beginning Cash Position : A$31.21 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Clarity Pharmaceuticals Beginning Cash Position?

Clarity Pharmaceuticals's Beginning Cash Position for the quarter that ended in Dec. 2023 was A$31.21 Mil.

Clarity Pharmaceuticals's quarterly Beginning Cash Position increased from Dec. 2022 (A$55.34 Mil) to Jun. 2023 (A$57.89 Mil) but then declined from Jun. 2023 (A$57.89 Mil) to Dec. 2023 (A$31.21 Mil).

Clarity Pharmaceuticals's annual Beginning Cash Position increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$8.44 Mil) and increased from Jun. 2022 (A$8.44 Mil) to Jun. 2023 (A$55.34 Mil).

Clarity Pharmaceuticals Beginning Cash Position Historical Data

The historical data trend for Clarity Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarity Pharmaceuticals Beginning Cash Position Chart

Clarity Pharmaceuticals Annual Data

Trend

Jun22

Jun23

Beginning Cash Position

8.44

55.34

Clarity Pharmaceuticals Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial			8.44	48.16	55.34	57.89	31.21

Clarity Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Clarity Pharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Clarity Pharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Clarity Pharmaceuticals (ASX:CU6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (ASX:CU6) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

CLRPF:USA

Address

4 Cornwallis Street, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015

Website

https://www.claritypharmaceuticals.com

Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.

Clarity Pharmaceuticals (ASX:CU6) Headlines

No Headlines